Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
13.2M
-
Number of holders
-
5
-
Total 13F shares, excl. options
-
2.15M
-
Shares change
-
+2.1M
-
Total reported value, excl. options
-
$743K
-
Value change
-
+$724K
-
Number of buys
-
5
-
Number of sells
-
-2
-
Price
-
$0.35
Significant Holders of Glucotrack, Inc. - Common Stock (GCTK) as of Q2 2023
7 filings reported holding GCTK - Glucotrack, Inc. - Common Stock as of Q2 2023.
Glucotrack, Inc. - Common Stock (GCTK) has 5 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.15M shares
of 13.2M outstanding shares and own 16.3% of the company stock.
Largest 7 shareholders include SABBY MANAGEMENT, LLC (2.03M shares), ALERUS FINANCIAL NA (69.3K shares), Warberg Asset Management LLC (30K shares), TWO SIGMA SECURITIES, LLC (19K shares), UBS Group AG (800 shares), BOSTON FINANCIAL MANGEMENT LLC (0 shares), and SUSQUEHANNA INTERNATIONAL GROUP, LLP (0 shares).
This table shows the top 5 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.